EXAGEN INC. (XGN) Form 10-K Annual Reports
EXAGEN INC. (XGN) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XGN
CIK: 1274737
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerSamuel Najewicz
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-02 | 2026-09-01 | FORM 4 | 0001449439-26-000007 | View SEC Doc Filr Page |
| 4/A | 2026-08-24 | 2026-06-09 | FORM 4/A | 0001289625-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-06-09 | FORM 4 | 0001274737-26-000056 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-06-09 | FORM 4 | 0001274737-26-000054 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001274737-26-000048 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 10-Q | 0001274737-26-000047 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-09 | FORM 4 | 0001274737-26-000043 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-09 | FORM 4 | 0001274737-26-000038 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-09 | FORM 4 | 0001782815-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | 8-K | 0001274737-26-000033 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-27 | — | SCHEDULE 13G Filing | 0002075833-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-20 | — | SCHEDULE 13G/A Filing | 0000921895-26-001461 | View SEC Doc Filr Page |
| S-8 | 2026-05-12 | — | S-8 | 0001274737-26-000031 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001274737-26-000029 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001274737-26-000027 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001274737-26-000022 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001274737-26-000021 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-09 | DEF 14A | 0001274737-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-17 | 8-K | 0001274737-26-000015 | View SEC Doc Filr Page |
| 3/A | 2026-04-21 | 2025-07-17 | FORM 3/A | 0001274737-26-000013 | View SEC Doc Filr Page |
| 3 | 2026-03-16 | 2026-03-16 | FORM 3 | 0001274737-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-03-16 | 2026-03-12 | FORM 4 | 0001449439-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-03-16 | 2026-03-12 | FORM 4 | 0001843113-26-000006 | View SEC Doc Filr Page |
| 10-K | 2026-03-10 | 2025-12-31 | 10-K | 0001274737-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-03-10 | 2026-03-10 | 8-K | 0001274737-26-000007 | View SEC Doc Filr Page |